HealthcareFree to read online

Endocrinology and Diabetes Management: A Practical Reference

Name: Endocrinology and Diabetes Management: A Practical Reference
Availability: InStock
Author: Dr. Kenji Yamamoto

How hormones work, how diabetes is diagnosed and treated, and how care teams organize monitoring and follow-up

This reference explains how the endocrine system regulates the body through hormones, and why a single gland fault can affect many organs. It covers how diabetes is classified and diagnosed, what continuous glucose monitoring and insulin delivery add to daily care, and how multidisciplinary teams organize education, follow-up and complication checks. The book closes with prevention, screening, common mistakes and a review of the core ideas.

Dr. Kenji Yamamoto, Academic Expert, Healthcare
18 min read
25 pages

Start reading

What you will learn

Describe how hormones are produced, signaled and regulated across the endocrine system
Distinguish major diabetes types and the diagnostic tests used to identify them
Explain how glucose monitoring and insulin delivery technologies support self-management
Outline how multidisciplinary teams plan, coordinate and review diabetes care
Identify screening, prevention and common mistakes in endocrine and diabetes practice

vaayaa Guide

vaayaa

Healthcare · Reference Guide

Endocrinology and Diabetes Management: A Practical Reference

How hormones work, how diabetes is diagnosed and treated, and how care teams organize monitoring and follow-up

Dr. Kenji YamamotoAcademic Expert, Healthcare

Orientation

001

What Endocrinology Covers

Endocrinology is the branch of medicine concerned with hormones, the chemical messengers that glands release into the blood. Hormones travel to target organs and tell them how fast to work, when to grow, how to store or use energy, and how to balance fluid and blood pressure. The endocrine system is made up of glands such as the thyroid, pituitary, adrenal glands, pancreas, parathyroids and gonads, and each one fits into a larger network of signals.

Because hormones act across the whole body, a problem in one gland rarely stays in one place. Too much thyroid hormone can speed the heart and wear down muscle. Too little insulin can raise blood glucose and, over years, damage the eyes, kidneys, nerves and blood vessels. Endocrine practice therefore asks clinicians to look at patterns across organs rather than at a single symptom.

Hormones act as slow, long-range signals, so a fault in one gland can affect many organs at once.

Diabetes is the most common example of this whole-body reach. It is a disorder of glucose regulation that touches nearly every organ system, which is why it sits at the center of most endocrine practice. Learners who understand diabetes well are usually well prepared for the wider field.

Working in this area means combining physiology, laboratory interpretation, drug knowledge and patient communication. Clinicians also need to recognize when a condition needs referral to a specialist team.

Gland

Hormone

Target organ

Whole body

How a gland fault spreads

Orientation

002

Why Endocrine Disorders Matter

Endocrine disorders are common and often long lasting. They can develop slowly, sometimes without clear symptoms for years, and many need ongoing treatment rather than a single cure. Diabetes is the largest single group, but thyroid disease, adrenal disorders, pituitary tumors and bone and mineral problems also account for a significant share of specialist workload.

Public health planning reflects this burden. Health systems track endocrine conditions because they drive hospital use, medication costs and long-term complications. Iodine deficiency, for example, remains a preventable cause of thyroid disease that is addressed through population measures such as salt iodization.

Endocrine conditions are long term, so most care is about steady monitoring rather than one-time fixes.

The figures below are illustrative, not measured data. They show how a clinic caseload might be divided across the main groups, to help readers picture the mix of work. Actual distributions vary by population and setting.

For learners, the practical point is that endocrine care is continuous. Patients usually need repeated testing, dose adjustment and education over many years.

Diabetes

Thyroid

Adrenal

Pituitary

Bone

Illustrative clinic caseload mix (Illustrative)

Orientation

003

Milestones in Endocrine Training

Specialist training in endocrinology and diabetes follows a structured path. In many systems, a trainee builds competence in stages, with each stage ending in a formal review of progress. Reviews check whether the trainee has met the expected knowledge, clinical skills and professional behaviors for that point in training.

Training programs typically include supervised clinical work, procedural experience in areas such as interventional endocrinology, and time for quality improvement or scholarly projects. Assessment combines written examinations, workplace observation, logbooks and feedback from supervisors and colleagues.

Training is a sequence of checked stages, so knowing the milestones helps you plan your progress.

A common structure places the specialty exam roughly in the penultimate year of training, followed by final review and certification. Each program publishes its own blueprint so trainees know which topics are tested and how heavily they are weighted.

Learners outside a specific national system can still use this sequence as a model. Knowing the stages helps you plan study, record evidence and seek feedback at the right times.

Supervised Work

Stage Review

Specialty Exam

Final Review

Certify

Training moves through checked stages

Orientation

004

How Competence Is Mapped

Competence in endocrinology is often described in domains such as assessment and diagnosis, management and treatment, communication, professionalism and systems-based practice. Frameworks map each domain to specific tasks, so that educators and examiners can judge whether a learner can perform them safely.

Blueprints weight these domains differently. A specialty exam may give a large share of questions to diabetes and a smaller share to rarer disorders, reflecting how often clinicians meet each problem. Learners can use the weighting to decide where to spend study time.

Competence is judged across several domains and levels, not by a single test score.

Competence is also rated against levels. A learner may need to know the pharmacology of a drug in theory, demonstrate a technique such as insulin administration in practice, and counsel a patient on it effectively. Matrices help track which level has been reached in each domain.

The matrix below rates three example domains against three levels of expected performance. The ratings are a teaching device, not a fixed standard.

	Knowledge	Skill	Counseling
Diagnosis	●●●	●●	●●
Treatment	●●●	●●●	●●
Follow-up	●●	●●	●●●

Example domain ratings by level

Core Concepts

005

Core Concepts of Glucose Control

Blood glucose is kept within a narrow range by hormones, mainly insulin and glucagon. Insulin, made by beta cells in the pancreas, lowers blood glucose by helping cells take up glucose and by signaling the liver to store it. Glucagon, made by alpha cells, raises glucose when levels fall, by prompting the liver to release stored sugar.

Other hormones, including cortisol, growth hormone and adrenaline, can push glucose upward during stress or illness. Diabetes develops when insulin is missing, insufficient or not working well, so glucose stays too high for too long.

Glucose stays in range through a balance between insulin and counter-regulatory hormones.

Understanding this balance explains why treatment choices differ. A problem with insulin supply calls for different therapy than a problem with insulin resistance, and both differ from a condition driven by hormones that oppose insulin.

The map below shows the main ideas linked to glucose control. Each branch is a concept a learner should be able to explain in their own words.

Glucose
Control

Insulin

Glucagon

Liver

Muscle

Stress
hormones

Kidney

Main ideas in glucose control

Core Concepts

006

Classifying Diabetes Types

Diabetes is grouped by its cause, because the cause shapes the treatment. Type 1 diabetes results mainly from autoimmune destruction of insulin-producing beta cells, usually leaving the person with little or no insulin. It often begins in childhood or young adulthood, though it can appear at any age.

Type 2 diabetes involves a combination of insulin resistance and a gradual loss of insulin secretion. It is strongly linked to body weight, physical activity, age and family history. Gestational diabetes is glucose in tolerance first detected during pregnancy, and it carries risks for both mother and baby. Other forms include diabetes caused by genetic defects, pancreatic disease or medications.

Classifying diabetes by cause guides which treatment is appropriate from the start.

The classification is not always clean. Some adults present with features of both types, and a clinician may need follow-up testing to clarify the picture. Correct classification affects whether insulin is needed early and which drugs are appropriate.

The donut below is an illustrative split of diabetes types in a sample clinic, to help learners think about relative proportions. It is not a measured population figure.

Type 2 85%
Type 1 10%
Other 5%

Illustrative split of diabetes types (Illustrative)

Core Concepts

007

Shared Features Across Diabetes

Although the types differ in cause, they share features that clinicians track in every patient. These include the level of blood glucose, the presence of symptoms such as thirst and frequent urination, weight change, and the risk of acute complications such as ketoacidosis or dangerously low glucose.

The overlap is shown in the diagram. The shared core lies in the middle, where glucose control and complication screening apply to everyone with diabetes. Each type also carries its own distinctive features at the edges.

Glucose control and complication screening apply across all types of diabetes.

Learners should be able to state which features are common and which are specific. This helps when a patient's presentation is unclear, because the shared core still guides initial assessment even before the type is confirmed.

Complication screening is part of the shared core. Eye, foot, kidney and nerve checks apply across types, though the timing and intensity differ.

Type
1

Type
2

Shared
care

Overlap across diabetes types

Core Concepts

008

Levels of Diabetes Care

Diabetes care can be pictured as layers, from the foundation of everyday self-management up to specialist intervention. The base is daily life: food choices, physical activity, sleep, stress and medication taken as prescribed. Without this base, higher-level treatment has little effect.

Above the base sits routine clinical monitoring, including regular glucose measures, blood pressure, lipid review and kidney function tests. Next comes intensified therapy, which may involve multiple insulin doses, pumps or added medications. The top layer is specialist input for complex cases, such as pregnancy, severe hypoglycemia or unusual complications.

Most diabetes care rests on everyday self-management, with specialist input reserved for complex cases.

Moving up a level should be a response to need, not a default. Most people are managed well at the lower levels, and escalation happens when targets are missed or risks rise.

The pyramid below shows the four levels from base to top. Learners can use it to decide what level of support a situation calls for.

Specialist input

Intensified therapy

Routine monitoring

Self-management

Four levels of diabetes care

Core Concepts

009

The Care Cycle

Diabetes management is best understood as a repeating cycle rather than a single event. The cycle begins with assessment, which gathers history, examination findings and test results. The next step is planning, where the clinician and patient agree on targets and treatment. Treatment then starts, and the plan is put into practice at home and in the clinic.

The cycle closes with review. At each review, the team checks glucose data, symptoms, side effects and complication screening, then returns to assessment with new information. Because the cycle repeats, small changes are made often instead of large changes made rarely.

Diabetes care repeats as a cycle, so small adjustments at review keep control on track.

Reviewing is what keeps the cycle honest. If a target is missed, the next assessment should look for causes such as diet, timing of doses, illness or barriers to access before changing the drug.

Learners should practice moving around the cycle with a case, asking at each stage what information is needed and what decision follows.

Assess

Plan

Treat

Review

Repeating diabetes care cycle

Core Concepts

010

Diagnosing Diabetes Step by Step

Diagnosis of diabetes follows a sequence. First, the clinician takes a history of symptoms, family history and risk factors. Next, a laboratory test measures blood glucose or glycated hemoglobin, depending on the situation. A single abnormal result may need confirmation with a repeat test, unless symptoms and very high values make the diagnosis clear.

Once diabetes is confirmed, the clinician classifies the type using age at onset, body habitus, presence of ketones, antibodies where available and the course of the illness. This step matters because it decides the first treatment.

Diagnosis is a sequence of history, testing, confirmation and classification, not a single number.

Documentation closes the process. The diagnosis, type, test values and date are recorded so that later reviews can compare results over time.

The process below summarizes the steps a clinician follows from first contact to documented diagnosis. It is a general outline and should be adapted to local guidelines.

History

Test glucose

Confirm result

Classify type

Record diagnosis

Steps from suspicion to diagnosis

Methods

011

Reading Glucose Test Results

Several tests measure glucose, and each answers a different question. A fasting glucose shows the level after a period without food. A random glucose can be taken at any time and is most useful when symptoms are severe. A glycated hemoglobin test reflects average glucose over roughly the previous two to three months.

An oral glucose tolerance test measures how the body handles a sugar load and is used in some situations, including gestational diabetes screening. Each test has limits, such as conditions that change red cell turnover, which can affect glycated hemoglobin readings.

Each glucose test answers a different question, so the choice of test should match the clinical question.

Interpretation depends on context. A borderline result in an otherwise well person may call for repeat testing, while a clearly high result with classic symptoms may need prompt treatment.

Learners should note which test was used and under what conditions, because a result without context can mislead.

Clinical Question

Match Test

Note Conditions

Interpret Context

Match the test to the question

Methods

012

Quantifying Glucose Control

Glucose control is often summarized using a few measures. Glycated hemoglobin gives an average over months. Time in range, a measure from continuous monitoring, shows the share of time glucose stays within a chosen band. Glucose variability describes how widely values swing, which matters because large swings raise risk even when averages look acceptable.

Each measure answers a different question about control. Using one measure alone can hide problems, so clinicians usually review more than one.

Using more than one glucose measure gives a fuller picture than any single average.

Targets are set individually. Factors such as age, pregnancy, hypoglycemia risk, comorbidities and patient preference all shape the appropriate target.

The bars below show an illustrative comparison of how time might be spent across ranges for one example patient. The numbers are not from a source and are used only to illustrate how the measure is read.

Below range

In range

Above range

Illustrative time spent by glucose range (Illustrative)

Methods

013

Monitoring Over Time

Monitoring changes over time as treatment changes. A new diagnosis may call for frequent checks while the first doses are adjusted. Once control is stable, checks can be spaced out. Changes in illness, pregnancy, travel or medication can bring the schedule back to a more intensive level.

Routine complication checks run on a separate schedule. Eye examinations, foot checks, kidney function tests and blood pressure reviews occur at intervals set by guidelines, and they continue even when glucose looks well controlled.

Monitoring frequency should match how stable the treatment is, and complication checks run on their own schedule.

A clear schedule helps patients and teams know what to expect. Writing the schedule down and linking each check to a purpose reduces missed tests.

The timeline below shows an example year of checks for a person on stable treatment. Intervals vary by guideline and patient need.

Glucose review

Eye check

Kidney test

Foot check

Lipid review

Example monitoring schedule over a year

Methods

014

Assessing Practice Competence

Clinicians and learners are often assessed on how well they perform tasks such as gathering a history, planning a management strategy and monitoring progress. Assessment can use direct observation, feedback from colleagues and patients, and audit of clinical records.

Competence is judged over time. A competency that is expected at one year of training may be expected to a higher level at two years. Programs record the level expected at each stage and the evidence gathered.

Competence grows in stages, and assessment works best when tied to specific clinical tasks.

Assessment is most useful when it is linked to specific tasks. Rather than rating overall skill, an assessor may check whether the learner obtained a complete history, prioritized problems and adjusted a plan after a change in status.

The matrix below rates three example competencies against the progression from early to later training. The ratings are illustrative and show the idea of growing expectations.

	Early	Middle	Late
History	●●●	●●●	●●●
Planning	●	●●	●●●
Insulin skills	●	●●●	●●●

Example competencies across training stages

Methods

015

Pharmacology Essentials

Diabetes drugs fall into several classes, each with a different mechanism. Insulin replaces or supplements the hormone. Other agents act on the liver, on the gut, on the kidney or on insulin sensitivity. Each class has indications, contraindications, adverse effects and interactions that a clinician must know.

Learners should be able to describe, for each class, how it lowers glucose, when it is appropriate, what risks it carries and what monitoring it needs. Hypoglycemia is a key risk with some classes, while other classes carry risks related to weight, kidney function or fluid balance.

Every diabetes drug is chosen by weighing its mechanism, risks and fit with the individual patient.

Drug choice also considers cost, access, patient preference, comorbidities such as heart or kidney disease, and the goals of therapy. A drug that suits one patient may be a poor choice for another.

The map below lists the main ideas a learner should connect when studying a drug class. Each branch should be explained in clear language.

Drug
Classes

Mechanism

Indications

Risks

Monitoring

Patient
fit

Goals

Main ideas to connect for each drug class

Methods

016

Insulin Choice and Dosing

Insulin preparations differ in how quickly they start to work, how long they last and when they peak. Rapid-acting insulins cover meals. Long-acting insulins provide a steady background supply. Intermediate preparations sit between these. Clinicians combine them to match a patient's daily pattern and needs.

Dosing is individualized. A starting dose is often based on body weight and total daily requirement, then adjusted according to glucose readings, meal patterns and activity. Adjustments are made carefully to avoid hypoglycemia, which is a common and serious adverse effect.

Insulin regimens are built around a patient's daily pattern, and teaching the technique is as important as the dose.

Patients must be taught to inject correctly, rotate sites, store insulin properly and recognize and treat low glucose. Demonstration and counseling are part of the standard of care, not optional extras.

The donut below shows an illustrative split of how total daily insulin might be divided between basal and mealtime doses in one example regimen. It is an illustration of the idea, not a dosing guide.

Basal Insulin 50%
Mealtime Insulin 40%
Correction Dose 10%

Illustrative split, not a dosing guide (Illustrative)

Applications

017

Monitoring and Delivery Technology

Continuous glucose monitoring devices measure interstitial glucose throughout the day and night and send readings to a display or app. They show trends, not just snapshots, and can alert the user when glucose is rising or falling quickly. Insulin pumps deliver rapid-acting insulin continuously in small amounts and in bolus doses at meals.

When combined, monitoring and pump delivery can support tighter control with less hypoglycemia for some people. The combination still needs skilled use, because sensor errors, site problems and algorithm settings can all affect results.

Devices add data and automation, but outcomes depend on the user understanding and acting on what they show.

Technology does not replace education. Users must understand what the readings mean, when to act on alerts and how to troubleshoot devices. Teams review device data with the patient to guide changes.

The Venn diagram below shows how monitoring, delivery and patient education overlap. The strongest outcomes come from the shared center, where all three work together.

Monitoring

Delivery

Education

How monitoring, delivery and education overlap

Applications

018

Escalation Pyramid for Devices

Technology decisions can be arranged in layers. At the base, a person uses standard finger-prick testing and multiple daily injections. A step up adds a continuous glucose monitor for trend data. Higher still is an integrated system combining a monitor with a pump, sometimes with automated adjustments. The top layer is reserved for complex cases needing specialist setup.

Moving up the pyramid should match need, skill and access. A person who is not yet able to act on sensor alerts may do better at a lower layer until skills are established.

Device choices should climb one layer at a time, matched to clinical need and the user's skill.

Funding, training support and local availability also shape which layer is practical. Teams document the reasons behind each step so the choice is clear to later reviewers.

The pyramid below shows four layers from base to top. Each step should be justified by clinical need and the person's ability to use the technology.

Integrated system

Pump

Continuous monitor

Finger-prick injections

Layers of monitoring and delivery technology

Applications

019

Device Management Cycle

Device-based care also runs as a cycle. The team sets up the device, trains the user, reviews the data at intervals, adjusts settings and checks that the user is still comfortable and safe. Then the cycle begins again.

Setup covers sensor placement, pump programming and alert thresholds. Training covers everyday use, what to do when an alert sounds and how to handle a failed sensor or blocked site. Review looks at patterns in the data, such as recurring lows after exercise or highs after particular meals.

Device care is a repeating loop of setup, training, data review and small adjustments.

Adjustment is made in small steps, and each change is recorded so the effect can be judged at the next review. Checking comfort and safety includes asking about skin reactions, sleep disruption and fear of low glucose.

Learners should practice this cycle with device data, identifying which pattern calls for which adjustment.

Set up

Train

Review data

Adjust

Repeating device management cycle

Applications

020

Team-Based Diabetes Care

Diabetes care is delivered by teams rather than single clinicians. A typical team may include an endocrinologist or diabetes physician, a diabetes educator, a dietitian, nurses, a pharmacist and mental health or social care staff. Each member brings a different skill, and the team works from a shared plan.

Education is central to the team's role. Patients learn how food, activity, medication and illness affect glucose, and how to recognize and treat problems. Dietitians help build eating plans that suit a person's culture, preferences and budget. Pharmacists check interactions and support medication adherence.

Diabetes care works best when a team shares one plan and each member owns a clear part of it.

Coordination matters as much as expertise. Teams agree on who follows up pending results, who answers patient calls and how referrals are closed with primary care. Clear written consultation to referring clinicians helps prevent gaps.

The process below shows how a referral typically moves through a diabetes team. The exact roles vary by system.

Referral

Assessment

Team plan

Education

Follow-up

Typical flow of a diabetes referral

Applications

021

Decisions in Everyday Practice

Clinicians make many decisions about diabetes care each week. Some concern treatment changes, such as adding a drug after glucose remains above target. Others concern referral, such as when to involve a specialist for pregnancy, frequent hypoglycemia or complex complications.

Good decisions weigh benefit against risk for the individual. A tighter glucose target may reduce some complications but raise the risk of dangerous lows in an older person living alone. Decisions should be shared with the patient, who knows their own circumstances.

A good diabetes decision balances the benefit of tighter control against the individual's risk of harm.

Documenting the reasoning behind each decision helps later clinicians understand what was tried and why. It also supports continuity when care moves between settings.

The process below outlines a simple decision path for adjusting therapy after review. It is a teaching outline, not a substitute for guidelines.

Review data

Check safety

Discuss options

Change plan

Simple path for adjusting therapy

Practice and Review

022

Common Mistakes and Fixes

Several mistakes recur in diabetes practice. One is treating a single high reading without checking for causes such as illness, missed doses or poor insulin storage. Another is intensifying therapy too quickly, which raises hypoglycemia risk. A third is skipping complication screening because glucose looks acceptable.

Another common mistake is teaching the technique once and assuming it is retained. Skills such as injection, sensor insertion and hypoglycemia treatment should be checked again at follow-up. Failing to ask about mood, distress or financial strain can also undermine a plan that looks good on paper.

Most diabetes mistakes come from acting on one data point or assuming a skill is retained without rechecking.

Each mistake has a practical fix. Review the cause before changing the drug. Lower doses carefully and recheck. Keep complication checks on schedule. Use demonstration and teach-back to confirm skills. Ask openly about barriers.

The matrix below rates how often each mistake occurs against how easily it is caught. The ratings are illustrative and meant as a teaching aid.

Single Reading

Fast Titration

Skipped Screening

One Teaching

Ignored Barriers

Illustrative teaching aid, not a rate survey (Illustrative)

Practice and Review

023

Screening and Prevention

Prevention and screening are central to endocrine care. Screening aims to find people with diabetes or prediabetes before symptoms appear, so that lifestyle support or treatment can begin early. Risk assessment considers age, body weight, family history, ethnicity, blood pressure and past glucose results.

Prevention focuses on changes that lower risk, including healthier eating, regular physical activity, weight management and avoiding tobacco. Population measures also matter. Universal salt iodization, for instance, prevents iodine deficiency, a preventable cause of thyroid disorders and of developmental harm in the newborn.

Screening finds people early, but a positive result must be confirmed and explained before action.

Screening itself has limits. Tests can show false positives or false negatives, and a positive result needs confirmation. Teams should explain what a result means and what happens next.

The timeline below shows an illustrative screening pathway from initial risk assessment to a lifestyle program and follow-up testing. Timing depends on local guidance.

Risk assessment

Initial test

Confirm result

Lifestyle support

Follow-up test

Illustrative screening and prevention pathway

Practice and Review

024

Review and Next Steps

This reference has moved from the basics of the endocrine system to diagnosis, monitoring, technology, team care, decisions, mistakes and prevention. Each part builds on the last. Glucose control depends on hormones and organs. Diagnosis depends on tests interpreted in context. Treatment depends on the type of diabetes and the person's circumstances. Care is delivered as a repeating cycle by a team.

To review, return to the cycle of assessment, planning, treatment and review, and ask at each step what information is needed and what decision follows. Connect each drug or device to its risks and its fit with the patient.

Endocrine and diabetes care is learned through repeated cycles of assessment, treatment and review with a team.

Keep the common mistakes in mind. Act on patterns rather than single readings, recheck skills, and keep complication screening on schedule.

Next steps for learners include working through a few cases, reviewing a local guideline, and reading the blueprint for any specialty exam you plan to take.

	Understand	Apply	Explain
Physiology	●●●	●●	●●
Diagnosis	●●	●●●	●●
Team care	●●	●●	●●●

Final review of core skills

References

025

References and Learning Sources

vaayaa References

vaayaa Data Review, vaayaa Sprouter discourses on Endocrinology and Diabetes Managementhttps://vaayaa.com/sprouter
vaayaa Learning Research, vaayaa News on Anesthesiology, Pain and Palliative Medicinehttps://vaayaa.com/news
vaayaa Analysis, vaayaa Sprouter discourses on Cardiac Care Supporthttps://vaayaa.com/sprouter
vaayaa Insights, vaayaa News on Cardiology and Cardiovascular Carehttps://vaayaa.com/news

Learning Sources

Micro Degree Endocrinology and Diabetes Managementhttps://vaayaa.com/course/endocrinology-and-diabetes-management
Micro Degree Anesthesiology, Pain and Palliative Medicinehttps://vaayaa.com/course/anesthesiology-pain-and-palliative-medicine
Micro Degree Cardiac Care Supporthttps://vaayaa.com/course/cardiac-care-support
Micro Degree Cardiology and Cardiovascular Carehttps://vaayaa.com/course/cardiology-and-cardiovascular-care
Micro Degree Cardiothoracic and Vascular Surgeryhttps://vaayaa.com/course/cardiothoracic-and-vascular-surgery

Endocrinology and Diabetes Management: A Practical Reference

What you will learn

Contents

What Endocrinology Covers

Why Endocrine Disorders Matter

Milestones in Endocrine Training

How Competence Is Mapped

Core Concepts of Glucose Control

Classifying Diabetes Types

Shared Features Across Diabetes

Levels of Diabetes Care

The Care Cycle

Diagnosing Diabetes Step by Step

Reading Glucose Test Results

Quantifying Glucose Control

Monitoring Over Time

Assessing Practice Competence

Pharmacology Essentials

Insulin Choice and Dosing

Monitoring and Delivery Technology

Escalation Pyramid for Devices

Device Management Cycle

Team-Based Diabetes Care

Decisions in Everyday Practice

Common Mistakes and Fixes

Screening and Prevention

Review and Next Steps

References and Learning Sources

vaayaa References

Further Reading

Learning Sources

More in Healthcare

Gastroenterology and Hepatology: A Working Reference

Acute Care Surgery: Trauma, Emergency and Critical Care

Geriatric Medicine and Long-Term Care Explained

Gynecology and Reproductive Medicine Explained